Inotiv (NOTV) Net Income towards Common Stockholders (2010 - 2026)
Inotiv (NOTV) reported Net Income towards Common Stockholders of -$32.5 million for Q1 2026, down 118.4% on a YoY basis from $176.5 million in Q1 2025, and down 14.41% quarter-over-quarter from -$28.4 million in Q4 2025.
Inotiv (NOTV) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Inotiv has reported Net Income towards Common Stockholders for 17 years, with the latest figure at -$32.5 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 118.4% year-over-year to -$32.5 million; the trailing twelve-month figure through Mar 2026 stood at -$87.0 million (up 0.57% YoY), and the FY2025 full-year result was -$68.6 million, up 36.97% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$32.5 million, down from -$28.4 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $365000.0 in Q2 2023, with the low at -$244.2 million in Q3 2022.
- Historically, Net Income towards Common Stockholders has averaged -$35.2 million across 5 years, with a median of -$17.6 million in 2025.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 109.79% — and 2024, when it tumbled 7247.12%.
- Inotiv's Net Income towards Common Stockholders stood at -$87.3 million in 2022, then surged by 81.87% to -$15.8 million in 2023, then slumped by 74.56% to -$27.6 million in 2024, then retreated by 2.71% to -$28.4 million in 2025, then declined by 14.41% to -$32.5 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$32.5 million (Q1 2026), -$28.4 million (Q4 2025), and -$8.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 141.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Inotiv | 2.76 Mn | -12.42 Mn | 111.99 Mn | -32.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.47 Mn |
| Dec 31, 2025 | -28.38 Mn |
| Sep 30, 2025 | -8.55 Mn |
| Jun 30, 2025 | -17.58 Mn |
| Mar 31, 2025 | -14.87 Mn |
| Dec 31, 2024 | -27.63 Mn |
| Sep 30, 2024 | -18.89 Mn |
| Jun 30, 2024 | -26.09 Mn |
| Mar 31, 2024 | -48.08 Mn |
| Dec 31, 2023 | -15.83 Mn |
| Sep 30, 2023 | -8.71 Mn |
| Jun 30, 2023 | 365,000.00 |
| Mar 31, 2023 | -9.63 Mn |
| Dec 31, 2022 | -87.32 Mn |
| Sep 30, 2022 | -244.16 Mn |
| Jun 30, 2022 | -3.73 Mn |
| Mar 31, 2022 | -6.09 Mn |
| Dec 31, 2021 | -83.05 Mn |
| Sep 30, 2021 | 9.38 Mn |
| Jun 30, 2021 | 2.60 Mn |